People in the following groups can choose to get a 2nd booster of either Pfizer-BioNTech or Moderna COVID-19 vaccine at least 4 months after the 1st booster:
Where to donate books near me in iowa series#
Learn when you can get your 2nd booster below and what you should consider.ĬDC recommends a booster of either Pfizer-BioNTech or Moderna COVID-19 vaccine:įor most people, at least 5 months after the final dose in the primary seriesįor people who are moderately or severely immunocompromised, at least 3 months after the final dose in the primary series People who got 2 doses (1 primary dose and 1 booster) of Johnson & Johnson’s Janssen vaccine People ages 12 years and older who are moderately or severely immunocompromised Learn when you can get your 1st booster below. You may get Johnson & Johnson’s Janssen COVID-19 vaccine in some situations.Įveryone ages 12 years and older can get 1 booster after completing their COVID-19 vaccine primary series. Pfizer-BioNTech or Moderna (COVID-19 mRNA vaccines) are preferred. Three COVID-19 vaccines are authorized or approved for use in the United States to prevent COVID-19. Get more information for people with allergies. If you aren’t able to get this vaccine, you may still be able to get a different type of COVID-19 vaccine.
A person with a severe allergic reaction needs to be treated with epinephrine (often given as an EpiPen) and should seek immediate medical attention. If you had a severe allergic reaction after getting a dose of the Pfizer-BioNTech COVID-19 vaccine, you should not get another dose of an mRNA vaccine.Ī severe allergic reaction can cause a rapid heartbeat, difficulty breathing, swelling of the throat, or a generalized rash or hives. If you have had a severe allergic reaction to any ingredient in the Pfizer-BioNTech COVID-19 vaccine (such as polyethylene glycol), you should not get this vaccine.
Where to donate books near me in iowa verification#
In clinical trials, the vaccine also had >90% efficacy in preventing COVID-19 among people of diverse age, sex, race, and ethnicity categories and among people with underlying medical conditions.Įvidence shows mRNA COVID-19 vaccines offer similar protection in real-world conditions as they have in clinical trial settings―reducing the risk of COVID-19, including severe illness by 90% or more, among people who are fully vaccinated.ĬDC will continue to provide updates as we learn more.Īlready vaccinated? You can find out more about vaccine verification here.
In clinical trials, the Pfizer-BioNTech vaccine had >90% efficacy in preventing laboratory-confirmed COVID-19 infection in children ages 5–15 years, and the immune response in children ages 5–15 years was at least as strong as the immune response in people ages 16–25 years. Learn more about how the Centers for Disease Control and Prevention (CDC) is making COVID-19 vaccine recommendationsīased on evidence from clinical trials in people ages 16 years and older, the Pfizer-BioNTech (COMIRNATY) vaccine was 95% effective at preventing laboratory-confirmed infection with the virus that causes COVID-19 in people who received two doses and had no evidence of being previously infected.
The Pfizer-BioNTech vaccine is recommended for people ages 5 years and older. Set your location Pfizer vaccine key takeaways It seems that you have not selected any location.